The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of potential predictive biomarkers of response to nivolumab in CheckMate-141 in patients with squamous cell carcinoma of the head and neck (SCCHN).
 
Robert L. Ferris
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Merck; Ono Pharmaceutical
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; VentiRx
 
Fernando Concha-Benavente
No Relationships to Disclose
 
George R. Blumenschein
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Merck; Novartis; Xcovery
 
Kevin J. Harrington
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck
 
Jerome Fayette
Leadership - Glycotope GmbH
Honoraria - AstraZeneca; Bristol-Myers Squibb
 
A. Dimitrios Colevas
Stock and Other Ownership Interests - Gilead Sciences; Pharmacyclics
Research Funding - Bristol-Myers Squibb; Curis; Genentech
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Debiopharm Group; Eisai; GlaxoSmithKline; Merck Serono; MSD; Novartis; SOBI; VentiRx
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Debiopharm Group; Merck Serono; MSD; sobi
 
Stefan Kasper
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Caroline Even
Consulting or Advisory Role - AstraZeneca; Innate Pharma; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Maura L. Gillison
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Lilly; Merck
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Lilly; Merck
 
Francis Worden
No Relationships to Disclose
 
Nabil F. Saba
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer; VentiRx
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer; VentiRx
 
Robert I. Haddad
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Eisai; Merck
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Merck Serono; Otsuka
Consulting or Advisory Role - Bayer; MSD; Ono Pharmaceutical; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); NanoCarrier (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Yasuhisa Hasegawa
No Relationships to Disclose
 
Chia-Jui Yen
No Relationships to Disclose
 
Mark John Lynch
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Manish Monga
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
William J. Geese
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Lilly